Servicio Madrileño de SaludConsejería de Sanidad

Terms of Use: Recommendations are based on a pharmacogenetic algorithm developed in a cohort of patients with thromboembolic disease (Borobia et al. PloS One, 2012) and explained 60.6% of the variability in the dose required to achieve stable INR. This web site is not intended to substitute for care by a expert healthcare professional